Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: An EORTC early clinical studies group investigation-Reference-Cited by-同舟云学术

Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: An EORTC early clinical studies group investigation

Published:1997-06 Issue:6 Volume:8 Page:604-606
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Judson I.,Cerny T.,Epelbaum R.,Dunlop D.,Smyth J.,Schaefer B.,Roelvink M.,Kaplan S.,Hanauske A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/8/6/604/19481036/8-6-604.pdf

Reference8 articles.

1. CA,1992

2. An analysis of 134 phase II trials in non-small cell lung cancer IV;Kris,1985

3. Synthesis and reactions of a new class of orally active Pt(IV) antitumour complexes;Giandomeruco,1991

4. Preclinical antitumour evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum (IV): An orally active platinum drug;Kelland;Cancer Res,1993

5. Preclinical toxicology and tissue distribution of novel oral antitumour platinum complexes: Ammine/amine platinum (IV) dicarboxylates;McKeage;Cancer Chemother Pharmacol,1994

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy;Journal of Controlled Release;2023-09

2. Polysaccharide‑platinum complexes for cancer theranostics;Carbohydrate Polymers;2023-09

3. Synthesis and Structure of Arene Ru(II) N∧O-Chelating Complexes: In Vitro Cytotoxicity and Cancer Cell Death Mechanism;Organometallics;2020-04-08

4. Recent progress in polymer-based platinum drug delivery systems;Progress in Polymer Science;2018-12

5. Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms;Scientific Reports;2017-07-20